PCG
LGND icon

Private Capital Group’s Ligand Pharmaceuticals LGND Stock Holding History

Private Capital Group’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$9K Sell
165
-88
-35% -$4.99K 0.01% 1079
2022
Q1 		$18K Sell
253
-44
-15% -$3.19K ﹤0.01% 1074
2021
Q4 		$29K Hold
297
– – 0.01% 900
2021
Q3 		$26K Hold
297
– – 0.01% 950
2021
Q2 		$24K Hold
297
– – 0.01% 996
2021
Q1 		$28K Sell
297
-54
-15% -$5.11K 0.01% 881
2020
Q4 		$22K Sell
351
-835
-70% -$47.6K ﹤0.01% 1142
2020
Q3 		$71K Sell
1,186
-55
-4% -$3.75K 0.01% 569
2020
Q2 		$87K Buy
1,241
+334
+37% +$21.2K 0.02% 486
2020
Q1 		$41K Sell
907
-92
-9% -$5.21K 0.01% 726
2019
Q4 		$64K Hold
999
– – 0.01% 620
2019
Q3 		$62K Buy
999
+109
+12% +$6.84K 0.01% 674
2019
Q2 		$115K Buy
890
+105
+13% +$7.73K 0.03% 349
2019
Q1 		$62K Buy
785
+93
+13% +$7.05K 0.01% 668
2018
Q4 		$59K Sell
692
-172
-20% -$18.3K 0.01% 584
2018
Q3 		$147K Sell
864
-26
-3% -$3.92K 0.03% 320
2018
Q2 		$114K Buy
890
+32
+4% +$3.57K 0.02% 380
2018
Q1 		$88K Sell
858
-745
-46% -$73.7K 0.02% 454
2017
Q4 		$73K Buy
+1,603
New +$139K 0.02% 530

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $838M AUM 14.24% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Private Capital Group's LGND Position: Q2 2022 in Review

Private Capital Group reduced its Ligand Pharmaceuticals (LGND) stake by 35% in Q2 2022, selling an estimated $4.99K and leaving 165 shares worth $9K. The position accounts for 0.01% of the portfolio, ranked #1079.

Private Capital Group first reported a position in LGND in Q4 2017 and has held it in 19 quarters since. The position peaked at $147K in Q3 2018. 197 funds tracked by Wall St. Rank hold LGND as of Q2 2022.

  • Private Capital Group held 165 shares of Ligand Pharmaceuticals worth $9K as of Q2 2022.
  • Private Capital Group sold 88 Ligand Pharmaceuticals shares in Q2 2022, an estimated $4.99K.
  • Ligand Pharmaceuticals made up 0.01% of Private Capital Group's portfolio in Q2 2022, its #1079 holding.
  • Private Capital Group first reported a position in Ligand Pharmaceuticals in Q4 2017 and has held it in 19 quarters since.
  • Private Capital Group's Ligand Pharmaceuticals position peaked at $147K in Q3 2018.
  • 197 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.